How Much Did Cascade Biocatalysts Raise?
Funding & Key Investors

Cascade Biocatalysts has successfully secured a significant capital injection, bringing its total funding to $8M. This latest round, which accounts for $5.4M in new financing, underscores the company's rapid evolution within the biotechnology and chemical manufacturing sectors. By leveraging this strategic investment, the Denver-based firm is positioned to accelerate its operational capacity and solidify its market presence as a leader in advanced biocatalytic solutions.

The recent influx of capital represents a pivotal milestone for the organization, reflecting strong investor confidence in its proprietary chemical synthesis technologies. As the company transitions into a more mature phase of its lifecycle, this financial backing provides the necessary runway to scale production and expand its research and development initiatives on a global scale.

What is Cascade Biocatalysts?

Cascade Biocatalysts
ManufacturingChemicals & Related Products

Based in Denver, Colorado, Cascade Biocatalysts operates at the intersection of biotechnology and industrial chemical manufacturing. The company specializes in the development of high-efficiency biocatalysts designed to optimize chemical processes, reduce environmental impact, and improve yield for complex industrial applications. By integrating advanced biological engineering with traditional chemical manufacturing, Cascade Biocatalysts addresses critical inefficiencies in the supply chain, offering sustainable alternatives to conventional synthesis methods. Their market position is defined by a commitment to innovation in green chemistry, serving as a vital partner for enterprises seeking to modernize their production infrastructure through sustainable, high-performance chemical solutions.

How much funding has Cascade Biocatalysts raised?

Cascade Biocatalysts has raised a total of $8M across 2 funding rounds:

2023

Other Financing Round

$2.6M

2025

Stock/Share Issuance

$5.4M

Other Financing Round (2023): $2.6M with participation from Spacecadet, Boost VC, and Ten VC

Stock/Share Issuance (2025): $5.4M, investors not publicly disclosed

Key Investors in Cascade Biocatalysts

Spacecadet

Spacecadet is a marketing-focused venture capital firm that supports innovative founders by providing strategic storytelling, design, and PR services alongside capital investment.

Boost VC

Boost VC is a prominent deep tech investor specializing in frontier technologies, providing early-stage support and fellowship programs for startups pushing the boundaries of science.

Ten VC

Ten VC is an investment firm that participates in strategic funding rounds, focusing on high-growth potential companies within the technology and industrial sectors.

What's next for Cascade Biocatalysts?

With the recent infusion of capital, Cascade Biocatalysts is poised to enter a phase of aggressive scaling and market penetration. The strategic roadmap likely includes the expansion of its manufacturing facilities to meet increasing enterprise demand and the further refinement of its biocatalytic platforms to address new chemical verticals. By focusing on operational excellence and technological differentiation, the company aims to capture a larger share of the industrial chemical market. Future growth will be driven by the successful deployment of these resources to enhance product throughput and establish long-term partnerships with major industrial players, ensuring the company remains at the forefront of the sustainable chemical revolution.

See full Cascade Biocatalysts company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

Food & BeverageManufacturing
Cosmetics, Beauty Supply & Personal Care ProductsManufacturingSpa and Salon ManagementConsumer Services
Building MaterialsManufacturingFurniture
FurnitureManufacturingRetail

Frequently Asked Questions Regarding Cascade Biocatalysts Financial Insights

What are the most recent funding rounds that Cascade Biocatalysts has completed, and what were the funding rounds?
Cascade Biocatalysts has recently completed 2 funding rounds: Stock/Share Issuance on Aug 25, 2025, Other Financing Round on Aug 22, 2023.
What is the total amount of funding Cascade Biocatalysts has raised to date?
Cascade Biocatalysts has raised a total of $8M in funding to date.
How many funding rounds has Cascade Biocatalysts completed?
Cascade Biocatalysts has completed 2 funding rounds.
How much funding did Cascade Biocatalysts raise in its most recent funding round?
Cascade Biocatalysts raised $5.4M in its most recent funding round.
Which was the largest funding round in Cascade Biocatalysts's history?
The largest funding round in Cascade Biocatalysts's history was $5.4M.
See more information about Cascade Biocatalysts